About Enhancer
| Enhancer ID: | E_01_0093 |
| Species: | human |
| Position : | chr19:19142448-19144448   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Mantle cell lymphoma |
| Pubmed ID: | 31914533 |
| Enhancer experiment: | He staining, immunohistochemistry, fluorescence in situ hybridization |
| Enhancer experiment description: | The expression of MEF2B in MCL is related to the pathological subtypes, structural subtypes and the expression of SOX11, but not to the proliferation and prognosis. |
About Target gene
| Target gene : | MEF2B |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The expression of MEF2B in MCL is related to the pathological subtypes, structural subtypes and the expression of SOX11, but not to the proliferation and prognosis. |
About TF
| TF name : | -- |
| TF experiment: | HE?????????????? |
| TF experiment description: | The expression of MEF2B in MCL is related to the pathological subtypes, structural subtypes and the expression of SOX11, but not to the proliferation and prognosis. |
About Function
| Enhancer function : | The expression of MEF2B in MCL is related to the pathological subtypes, structural subtypes and the expression of SOX11, but not to the proliferation and prognosis. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The expression of MEF2B in MCL is related to the pathological subtypes, structural subtypes and the expression of SOX11, but not to the proliferation and prognosis. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene